Related Experiment Video
Updated: Oct 28, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
How the COVID-19 pandemic can distort risk adjustment of health plan payment
Richard C van Kleef1, Mieke Reuser2,3
1Erasmus School of Health Policy & Management, Rotterdam, The Netherlands. vankleef@eshpm.eur.nl.
Insights
The COVID-19 pandemic caused temporary shifts in healthcare use, impacting health plan payments. Understanding these disruptions is crucial for accurate risk adjustment and fair insurer payments.
Area of Science:
- Health Economics
- Healthcare Policy
- Epidemiology
Background:
- The COVID-19 pandemic significantly disrupted healthcare utilization and spending patterns globally.
- These disruptions include both persistent changes (e.g., telehealth adoption) and transitory effects (e.g., postponed procedures).
Purpose of the Study:
- To analyze the implications of transitory changes in healthcare utilization and spending on health plan payment risk adjustment.
- To introduce a framework for understanding pandemic-related distortions in risk adjustment methodologies.
- To illustrate potential under- or overpayments for health insurers due to these distortions.
Main Methods:
- Development of a conceptual framework to analyze distortions in risk adjustment steps.
- Calibration of payment weights using risk adjusters.
- Calculation of insurer payments based on enrollee characteristics and calibrated weights.
- Hypothetical illustration of payment distortions.
Main Results:
- Transitory changes in healthcare utilization and spending can distort risk adjustment processes.
- Potential for under- or overpayment of health insurers depending on several factors.
- The magnitude of payment distortions is influenced by the pandemic's impact on utilization, risk distribution, insurer-specific effects, and system design.
Conclusions:
- Transitory healthcare utilization shifts necessitate careful consideration within risk adjustment models.
- Accurate risk adjustment is vital to ensure equitable health plan payments amidst pandemic-related disruptions.
- Future risk adjustment systems may need to account for pandemic-induced volatility in healthcare utilization and spending.
Abstract:
The COVID-19 pandemic has led to disruptions in healthcare utilization and spending. While some changes might persist (e.g. substitution of specialist visits by online consultations), others will be transitory (e.g. fewer surgical procedures due to cancellation of treatments). This paper discusses the implications of transitory changes in healthcare utilization and spending for risk adjustment of health plan payment. In practice, risk adjustment methodologies typically consist of two steps: (1) calibration of payment weights for a given set of risk adjusters and (2) calculation of payments to insurers by combining the calibrated weights with enrollee characteristics. In this paper, we first introduce a simple conceptual framework for analyzing the (potential) distortions from the pandemic for both steps and then provide a hypothetical illustration of how these distortions can lead to under- or overpayment of insurers. The size of these under-/overpayments depends on (1) the impact of the pandemic on patterns in utilization and spending, (2) the distribution of risk types across insurers, (3) the extent to which insurers are disproportionately affected by the pandemic, and (4) features of the risk adjustment system.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Relative Risk
Preventive Healthcare Services
Standards of Care II
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment